STAGE II NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE II NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE II NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE II NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo shows promise in early lung cancer trial
Disease control CompletedThis early-phase trial tested the safety and best dose of adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy (paclitaxel and carboplatin) and radiation therapy for people with stage II to IIIB non-small cell lung cancer. The study enrolled 23 particip…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 22, 2026 11:54 UTC
-
New combo therapy shows promise for hard-to-treat lung cancer
Disease control CompletedThis study tested a combination of a cancer vaccine (TG4010) and an immunotherapy drug (nivolumab) in 13 people with advanced non-small cell lung cancer who had already received other treatments. The goal was to see if the combination could shrink tumors or stop them from growing…
Matched conditions: STAGE II NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC